IBDEI0KV ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9445,2)
 ;;=^5003967
 ;;^UTILITY(U,$J,358.3,9446,0)
 ;;=G46.8^^63^605^14
 ;;^UTILITY(U,$J,358.3,9446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9446,1,3,0)
 ;;=3^Vascular Syndromes of Brain in CVD,Other
 ;;^UTILITY(U,$J,358.3,9446,1,4,0)
 ;;=4^G46.8
 ;;^UTILITY(U,$J,358.3,9446,2)
 ;;=^5003968
 ;;^UTILITY(U,$J,358.3,9447,0)
 ;;=I67.2^^63^605^5
 ;;^UTILITY(U,$J,358.3,9447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9447,1,3,0)
 ;;=3^Cerebral Atherosclerosis
 ;;^UTILITY(U,$J,358.3,9447,1,4,0)
 ;;=4^I67.2
 ;;^UTILITY(U,$J,358.3,9447,2)
 ;;=^21571
 ;;^UTILITY(U,$J,358.3,9448,0)
 ;;=I69.898^^63^605^6
 ;;^UTILITY(U,$J,358.3,9448,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9448,1,3,0)
 ;;=3^Cerebrovascular Disease Sequelae,Other
 ;;^UTILITY(U,$J,358.3,9448,1,4,0)
 ;;=4^I69.898
 ;;^UTILITY(U,$J,358.3,9448,2)
 ;;=^5007550
 ;;^UTILITY(U,$J,358.3,9449,0)
 ;;=Z86.73^^63^605^9
 ;;^UTILITY(U,$J,358.3,9449,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9449,1,3,0)
 ;;=3^Personal Hx of TIA/Cerebral Inf w/o Resid Deficits
 ;;^UTILITY(U,$J,358.3,9449,1,4,0)
 ;;=4^Z86.73
 ;;^UTILITY(U,$J,358.3,9449,2)
 ;;=^5063477
 ;;^UTILITY(U,$J,358.3,9450,0)
 ;;=H81.10^^63^606^1
 ;;^UTILITY(U,$J,358.3,9450,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9450,1,3,0)
 ;;=3^Benign Paroxysmal Vertigo
 ;;^UTILITY(U,$J,358.3,9450,1,4,0)
 ;;=4^H81.10
 ;;^UTILITY(U,$J,358.3,9450,2)
 ;;=^5006864
 ;;^UTILITY(U,$J,358.3,9451,0)
 ;;=H81.49^^63^606^2
 ;;^UTILITY(U,$J,358.3,9451,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9451,1,3,0)
 ;;=3^Central Vertigo
 ;;^UTILITY(U,$J,358.3,9451,1,4,0)
 ;;=4^H81.49
 ;;^UTILITY(U,$J,358.3,9451,2)
 ;;=^5006883
 ;;^UTILITY(U,$J,358.3,9452,0)
 ;;=R55.^^63^606^4
 ;;^UTILITY(U,$J,358.3,9452,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9452,1,3,0)
 ;;=3^Syncope and Collapse
 ;;^UTILITY(U,$J,358.3,9452,1,4,0)
 ;;=4^R55.
 ;;^UTILITY(U,$J,358.3,9452,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,9453,0)
 ;;=R42.^^63^606^3
 ;;^UTILITY(U,$J,358.3,9453,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9453,1,3,0)
 ;;=3^Dizziness and Giddiness
 ;;^UTILITY(U,$J,358.3,9453,1,4,0)
 ;;=4^R42.
 ;;^UTILITY(U,$J,358.3,9453,2)
 ;;=^5019450
 ;;^UTILITY(U,$J,358.3,9454,0)
 ;;=F10.27^^63^607^1
 ;;^UTILITY(U,$J,358.3,9454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9454,1,3,0)
 ;;=3^Alcoholic Encephalopathy
 ;;^UTILITY(U,$J,358.3,9454,1,4,0)
 ;;=4^F10.27
 ;;^UTILITY(U,$J,358.3,9454,2)
 ;;=^5003095
 ;;^UTILITY(U,$J,358.3,9455,0)
 ;;=G92.^^63^607^4
 ;;^UTILITY(U,$J,358.3,9455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9455,1,3,0)
 ;;=3^Toxic Encephalopathy
 ;;^UTILITY(U,$J,358.3,9455,1,4,0)
 ;;=4^G92.
 ;;^UTILITY(U,$J,358.3,9455,2)
 ;;=^259061
 ;;^UTILITY(U,$J,358.3,9456,0)
 ;;=G96.8^^63^607^2
 ;;^UTILITY(U,$J,358.3,9456,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9456,1,3,0)
 ;;=3^Disorder of Central Nervous System,Other Spec
 ;;^UTILITY(U,$J,358.3,9456,1,4,0)
 ;;=4^G96.8
 ;;^UTILITY(U,$J,358.3,9456,2)
 ;;=^5004199
 ;;^UTILITY(U,$J,358.3,9457,0)
 ;;=G98.8^^63^607^3
 ;;^UTILITY(U,$J,358.3,9457,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9457,1,3,0)
 ;;=3^Disorder of Nervous System,Other
 ;;^UTILITY(U,$J,358.3,9457,1,4,0)
 ;;=4^G98.8
 ;;^UTILITY(U,$J,358.3,9457,2)
 ;;=^5004214
 ;;^UTILITY(U,$J,358.3,9458,0)
 ;;=G43.009^^63^608^7
 ;;^UTILITY(U,$J,358.3,9458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9458,1,3,0)
 ;;=3^Migraine w/o Aura Not Intractable 
 ;;^UTILITY(U,$J,358.3,9458,1,4,0)
 ;;=4^G43.009
 ;;^UTILITY(U,$J,358.3,9458,2)
 ;;=^5003877
 ;;^UTILITY(U,$J,358.3,9459,0)
 ;;=G43.019^^63^608^6
 ;;^UTILITY(U,$J,358.3,9459,1,0)
 ;;=^358.31IA^4^2
